Get started
BBB

BIOLIGHT

No trades
See on Supercharts
Overview
Financials Discussions Technicals Seasonals

BOLT chart


Full chart

Key stats


Market capitalization
‪20.55 M‬ ILS
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
—
Net income (FY)
—
Revenue (FY)
—
Shares float
—
Beta (1Y)
0.64

About BIOLIGHT


Sector
Health Technology
Industry
Medical Specialties
CEO
Yaacov Levi Michlin
Website
bio-light.co.il
Headquarters
Tel Aviv
Founded
2005
ISIN
IL0010952237
FIGI
BBG000BZQ6F1
BioLight Life Sciences Ltd. engages in investing in companies and managing projects in the field of eye diseases and ocular treatments. Its portfolio companies deals with advanced medical devices, medication, diagnostics, and digital healthcare. BioLight's portfolio includes: DiagnosTear's TeaRx, LipiCare, ViSci, OphRx, Peripherex, AEYE, Tarsier, Belkin Vision, and Sanoculis. The company was founded on April 20, 2005 and is headquartered in Tel Aviv, Israel.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of BOLT is 467.0 ILA — it has increased by 5.47% in the past 24 hours. Watch BIOLIGHT stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TASE exchange BIOLIGHT stocks are traded under the ticker BOLT.
BOLT stock has risen by 1.17% compared to the previous week, the month change is a 4.50% rise, over the last year BIOLIGHT has showed a −19.06% decrease.
BOLT reached its all-time high on Jul 19, 2007 with the price of 98,487.8 ILA, and its all-time low was 334.3 ILA and was reached on Apr 21, 2024. View more price dynamics on BOLT chart.
See other stocks reaching their highest and lowest prices.
BOLT stock is 7.82% volatile and has beta coefficient of 0.64. Track BIOLIGHT stock price on the chart and check out the list of the most volatile stocks — is BIOLIGHT there?
Today BIOLIGHT has the market capitalization of ‪20.62 M‬, it has decreased by −4.42% over the last week.
Yes, you can track BIOLIGHT financials in yearly and quarterly reports right on TradingView.
BOLT net income for the last half-year is ‪838.00 K‬ ILS, while the previous report showed ‪−19.02 M‬ ILS of net income which accounts for 104.40% change. Track more BIOLIGHT financial stats to get the full picture.
No, BOLT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, BOLT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BIOLIGHT stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BIOLIGHT technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BIOLIGHT stock shows the sell signal. See more of BIOLIGHT technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.